-
effectivehealthcare.ahrq.gov/sites/default/files/Evidence%20Summary_1.pdf
April 01, 2020 - Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: Evidence Summary
Purpose of Review
To summarize evidence on cognitive test accuracy for clinical
Alzheimer’s-type dementia (CATD) in suspected cognitive
impairment; biomarker accuracy for Alzheimer’s disease (AD)
in dementia; and effects of CATD drug …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
September 01, 2011 - Layout 1
Background
Juvenile idiopathic arthritis (JIA) is the
most common rheumatologic disease in
childhood, with an overall prevalence of 7
to 400 per 100,000 children. JIA is an
important cause of chronic disease in
childhood, with prevalence similar to type I
diabetes mellitus. Several classification
systems ha…
-
effectivehealthcare.ahrq.gov/sites/default/files/hibbard-presentation.pdf
May 29, 2025 - And then the next week I was in
the U.K. and I sat down with
people from the NHS Kidney Foundation
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea-treatment-future_research.pdf
February 01, 2012 - The discussion boards were
initially scheduled to be open for a 2-week period. … During the open period, stakeholders were
regularly encouraged (two to four times per week) to contribute … To improve participation, after 1 week of discussion, we invited all stakeholders (from both
panels) … dichotomized outcome of at least 4 hours of use per night for more than 70 or 80 percent
of the nights per week … When the discussion period was announced, few participants
logged onto the Web site within the first week
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypertension-pulmonary-arterial_research-protocol.pdf
January 30, 2013 - Source: www.effectivehealthcare.ahrq.gov
Published online: January 30, 2013 1
Evidence-based Practice Center Systematic Review Protocol
Project Title: Pulmonary Arterial Hypertension: Screening, Management, and Treatment
Amendment Date(s): January 28, 2013
(Amendment Details – see Section VII)
I. Back…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_disposition-comments.pdf
October 27, 2015 - Each research review is posted to the EHC Program
Web site in draft form for public comment for a 3-week
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-274-tethered-spinal-cord-disposition-comments.pdf
October 25, 2024 - draft report is posted to the EHC Program website
or AHRQ website for public comment for a 3- to 4-week
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/research-gap-primary-care-summary-table.pdf
March 01, 2022 - pain relief
at 2 hours and increase the likelihood of being pain-
free at 2 hours, 1 day, and at 1 week … Pain during the week or month following
the inciting event and persistent opioid use were
rarely reported
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1312.pdf
October 01, 2014 - Only a fraction of treated patients responds within a week
of starting any of the many medications … 1,200 mg of mifepristone is being administered
orally, in four 300 mg tablets, once daily, for a week … infrastructure and patient management would
primarily result from the addition of multiple visits per week … depressive
symptoms to a single intravenous infusion of
ketamine vs add-on riluzole: results from a 4-
week
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-pain-management-grand-rounds-slides.pptx
March 01, 2022 - AHRQ Slide Template
AHRQ Evidence-based Practice Center (EPC) Program
Welcome and thank you for joining the EPC Grand Rounds
Full EPC Report Links
The information provided in this presentation only represents a summary of report data. For detailed information, please visit the AHRQ website links below to read the …
-
effectivehealthcare.ahrq.gov/sites/default/files/cardiovascular-horizon-scan-high-impact-1412.pdf
December 01, 2014 - By week 56, LDL-C concentrations were reduced by 44%
(95% confidence interval [CI], -57% to -31%; p … At week 78, LDL-C
concentrations were reduced by 38% (-52% to -24%; p<0.0001). … By week 56, LDL-C
concentrations remained reduced by 44% (95% confidence interval [CI], -57 to -31; … At
week 78, LDL-C concentrations were reduced by 38% (-52 to -24; p<0.0001). … At week 126, mean LDL-C concentrations were reduced from baseline by
45.5% (356±127 mg/dL vs. 189±120
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/pelvic-pain-therapies-future_research.pdf
January 01, 2015 - The survey was open for one week, at which point five stakeholders had completed the survey. … greater)
o History of jaundice or
Drug: Duloxetine
30 mg dose once
daily, administered
orally for 1 week … once daily,
administered orally for
5 weeks, 30 mg dose
once daily,
administered orally for
1 week … AST,ALT, bilirubin, or Alkaline
Phosphatase), tested at the
screening period, after the first
week … increasing in weekly
increments to a
maximum dose of
2700mg if pain has
not been reduced by
50% each week
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs_research-protocol.pdf
December 16, 2011 - Source: www.effectivehealthcare.ahrq.gov
Published Online: December 16, 2011
1
Evidence-based Practice Center Systematic Review Protocol
Project Title: Comparative Effectiveness of Treatments for Restless Legs Syndrome
I. Background and Objectives for the Systematic Review
Overview
Restless legs syndr…
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_4-user-guide-to-ocer_130129.pdf
January 01, 2010 - exposure to these two medications, it would
be insufficient to examine medication use
in the last week
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-264-maternal-morbidity-mortality-disposition-comments.pdf
December 21, 2023 - draft report is posted to the EHC Program website or
AHRQ website for public comment for a 3- to 4-week
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-2-risk-of-reinfection-from-SARSCoV2_0.pdf
December 31, 2022 - Version 2_Risk of Reinfection From SARS-CoV-2 -- An Update of an Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: A Living Rapid Review
Rapid Evidence Product
Version 2.0 (January 2022)
Risk of Reinfection From SARS-CoV-2 – An
Update of an Antibody Response Following
SARS-Co…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_clinician-2016.pdf
January 01, 2016 - Behavioral Programs for Type 1 Diabetes Mellitus: Current State of the Evidence
Behavioral Programs for Type 1 Diabetes Mellitus:
Current State of the Evidence
Focus of This Summary
This is a summary of a systematic review evaluating the evidence about the effectiveness of behavioral programs for type 1
diabete…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_executive.pdf
September 01, 2014 - randomly divided 160 women at 26 to less
than 30 weeks gestation to receive 35,000 IU vitamin
D per week
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-243-prehospital-airway-management-evidence-summary_0.pdf
June 01, 2021 - Comparative Effectiveness Reiew 243_Prehospital Airway Management: A Systematic Review
Comparative Effectiveness Review
Number 243
Prehospital Airway Management:
A Systematic Review
Evidence Summary
Main Points
• Four Key Questions addressed the comparative benefits and harms across …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-off-label-update_research-protocol.pdf
May 19, 2010 - Evidence Report on the
Source: www.effectivehealthcare.ahrq.gov
Published Online: May 19, 2010
Evidence-based Practice Center Systematic Review Protocol
Project Title: Efficacy and Comparative Effectiveness of Off-Label Use of Atypical
Antipsychotics – Update
I. Background and Objectives for the Sys…